MONDAY, Nov. 13, 2023 (Healthday News) — Two new gene-editing treatments that target dangerously high levels of cholesterol in people with a genetic predisposition to the condition were found safe and effective in new, groundbreaking research. While powerful drugs like statins can help manage cholesterol in most people, they can’t treat those who have genes that…  read on >  read on >

KEY TAKEAWAYS: The progression of multiple sclerosis is particularly difficult to predict, varying widely between patients A new blood test uses a biomarker of nerve cell damage to accurately predict progression over the next two years If the test proves valid, it might help patients and their doctor plan optimal treatments, the researchers said One…  read on >  read on >

Climate change-driven hurricanes, floods and superstorms are threatening to create a surge in mold growth in people’s homes, sickening residents and robbing them of breath. Local hospitals witness a nearly twofold increase in diagnoses related to mold exposure following a storm-related natural disaster, according to a study being presented Thursday at the annual meeting of…  read on >  read on >

Young people who smoke and have prediabetes have triple the risk of suffering a stroke, a new study shows. Overall, hospitalized tobacco users with prediabetes had a 3.3 times higher risk that they were in the hospital due to a stroke, after researchers accounted for other risk factors. The findings “warrant early screening and prevention…  read on >  read on >

An experimental device that isolates blood flow to the brain has the potential to revolutionize brain research. The device redirects the brain’s blood supply through a pump that maintains or adjusts a range of variables necessary to maintain the organ, including blood pressure, temperature, oxygenation and nutrients, researchers report. When tested on a pig brain,…  read on >  read on >

FRIDAY, Nov. 10, 2023 (Healthday News) — The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults who are at increased risk of exposure to the virus. “Infection with chikungunya virus can lead to…  read on >  read on >